A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/713 (2006.01) A61K 9/14 (2006.01) C12N 15/113 (2010.01) A61K 47/36 (2006.01) C12N 15/87 (2006.01)
Patent
CA 2731399
The present invention provides nanoparticles for treatment of inflammatory diseases. The nanoparticles preferably comprise chitosan and a siRNA targeting a mRNA encoding a pro-inflammatory cytokine, such as e.g. tnf-alfa. A preferred route of administration of the nanoparticles is by injection intraperitoneally.
La présente invention concerne des nanoparticules destinées au traitement de maladies inflammatoires. Lesdites nanoparticules comprennent de préférence du chitosane et un siRNA qui cible un mRNA codant pour une cytokine pro-inflammatoire, telle que tnf-alfa par exemple. L'une des voies d'administration préférée desdites nanoparticules est l'injection intrapéritonéale.
Besenbacher Flemming
Deleuran Bent
Howard Kenneth Alan
Kjems Joergen
Aarhus Universitet
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Nanoparticle-mediated treatment for inflammatory diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nanoparticle-mediated treatment for inflammatory diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanoparticle-mediated treatment for inflammatory diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1890644